Status:
COMPLETED
BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
Sarcoma, Soft Tissue
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The aim of this study (\*) is to evaluate the progression free survival rate at 6 months, response rate, overall disease control rate, overall survival of BAY-43-9006 in soft tissue sarcoma patients. ...
Eligibility Criteria
Inclusion
- Histologically documented, progressive, advanced or metastatic sarcoma after adjuvant and/or first line anthracycline-based regimen; age \>=18 yrs; ECOG PS =2; at least 1 measurable target lesion; life expectancy \>=12 wks; adequate medullary liver and renal function; written informed consent.
Exclusion
- metastatic brain disease; pregnant or breast-feeding patients; serious infections.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00406601
Start Date
November 1 2006
End Date
September 1 2010
Last Update
September 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Clinico Humanitas
Rozzano, Milan, Italy, 20089